Textbook of Developmental Biology: Laboratory Techniques and Experimental Approaches
暫譯: 發展生物學教科書：實驗室技術與實驗方法

Prof. Alok Chandra Bharti, a Banaras Hindu University doctorate with 29 years' experience in molecular oncology, conducted pioneering research at MD Anderson Cancer Center, Texas, on NF-κB and STAT3 in carcinogenesis, diagnostics, and therapeutic targeting. Currently serving as professor at the Uni. of Delhi, Dr. Bharti held a Senior Scientist role at ICMR's National Institute of Cancer Prevention and Research for 12 years. He has published 104 international peer-reviewed papers and 20 book chapters, guided 19 Ph.D. students. His work focuses on developing affordable diagnostics for HPV-associated cancers and advancing research on cervical cancer stem cells, particularly in identifying circulating tumor cells as diagnostic markers. In 2008, he was nominated advisor to the WHO-HPV Laboratory Network. Prof. Bharti's accolades include the INSA Medal for Young Scientist (2009) and Senior Research Fellowships from ICMR and INSA (2012, 2018). He has the expertise in working with mouse and chick embryo models.

Dr. Anna Senrung is a faculty in the Dept. of Zoology at Daulat Ram College (DRC), Uni. of Delhi, with over 11 years of teaching and research experience. An active researcher, Dr. Senrung specializes in angiogenesis and the tumor microenvironment of Glioblastoma, utilizing chick embryos as a model system, and has authored four publications on chick embryo studies and culture apart from other publications in national and international journals as well as in conference proceedings. Dr. Senrung actively mentors students at DRC in cancer research techniques and in silico drug discovery. Dr. Senrung has also contributed as a resource person for Chick embryo culture for in-house as well as external workshops. Beyond academics and research, during her tenure as the Nodal officer of the NE Cell at DRC, she organized programs supported by the Ministry of DoNER, ICPR and the P. A. Sangma Foundation, Meghalaya.

Dr. Ashok Kumar has been a tenured Else and Philip Hargrove Endowed Professor of Drug Discovery at the Uni. of Houston (UH) since 2019. With over 32 years of research and teaching experience, he is the founding Director of UH's Institute of Muscle Biology and Cachexia. Prior to joining UH, Dr. Kumar served as a Professor and Distinguished Uni. Scholar in Anatomical Sciences and Neurobiology at the Uni. of Louisville School of Medicine. Dr. Kumar's research has made significant contributions to biomedical science, notably identifying TWEAK as a key cytokine involved in muscle wasting. He has elucidated the roles of major signaling molecules, including TRAF6, TAK1, IRE1, PERK, and MyD88, in regulating skeletal muscle mass and cancer cachexia. His research program extensively employs nude, knockout, and transgenic mouse models. Dr. Kumar has authored 120+ peer-reviewed publications, mentored over 60 students, postdocs, and junior faculty, and regularly reviews for 70+ journals and major funding agencies, including the NIH.

Dr. Gautam Sethi is an Associate Prof. in the Dept. of Pharmacology at the Yong Loo Lin School of Medicine, National Uni. of Singapore. His research primarily explores the mechanisms by which carcinogens and inflammatory agents activate oncogenic transcription factors, aiming to identify novel inhibitors for cancer prevention and treatment using diverse model systems. His work has led to 500+ scientific publications in high-impact peer-reviewed journals. Additionally, Dr. Sethi contributes to the scientific community as an editorial board member and ad-hoc reviewer for numerous prestigious international journals, supporting advancements in pharmacology and cancer research. He is highly regarded globally, consistently recognized as one of the world's most-cited scientists, and was named among Clarivate's Highly Cited Researchers(TM) in 2020 and 2021. Additionally, he has been featured in Stanford Uni. World's Top 2% Scientists List for 2020-2025 in oncology and carcinogenesis.

阿洛克·昌德拉·巴爾提教授，擁有班納拉斯印度大學的博士學位，擁有29年的分子腫瘤學經驗，在德克薩斯州的MD安德森癌症中心進行了關於NF-κB和STAT3在致癌、診斷和治療靶向方面的開創性研究。目前擔任德里大學的教授，巴爾提博士曾在印度醫學研究委員會（ICMR）的國家癌症預防與研究所擔任高級科學家12年。他已發表104篇國際同行評審的論文和20章書籍，指導19名博士生。他的研究重點是開發可負擔的HPV相關癌症診斷方法，並推進有關子宮頸癌幹細胞的研究，特別是在識別循環腫瘤細胞作為診斷標記方面。2008年，他被提名為世界衛生組織（WHO）HPV實驗室網絡的顧問。巴爾提教授的榮譽包括2009年的印度科學院年輕科學家獎（INSA Medal for Young Scientist）以及2012年和2018年的ICMR和INSA高級研究獎學金。他在小鼠和小雞胚胎模型方面擁有專業知識。

安娜·森榮博士是德里大學達烏拉特·拉姆學院（DRC）動物學系的教員，擁有超過11年的教學和研究經驗。作為一名活躍的研究者，森榮博士專注於血管生成和膠質母細胞瘤的腫瘤微環境，利用小雞胚胎作為模型系統，並在小雞胚胎研究和培養方面發表了四篇論文，此外還在國內外期刊及會議論文集中發表了其他研究。森榮博士積極指導DRC的學生掌握癌症研究技術和計算機輔助藥物發現。她還作為小雞胚胎培養的資源人員，為內部和外部的工作坊提供支持。除了學術和研究外，在擔任DRC的NE小組聯絡官期間，她組織了由印度部門（Ministry of DoNER）、ICPR和梅加拉亞的P.A.桑瑪基金會支持的項目。

阿肖克·庫馬博士自2019年以來一直擔任休斯頓大學（UH）藥物發現的終身教職Else和Philip Hargrove捐贈教授。擁有超過32年的研究和教學經驗，他是UH肌肉生物學與惡病質研究所的創始主任。在加入UH之前，庫馬博士曾在路易斯維爾大學醫學院擔任解剖科學和神經生物學的教授和傑出學者。庫馬博士的研究對生物醫學科學做出了重要貢獻，特別是確定了TWEAK作為參與肌肉萎縮的關鍵細胞因子。他闡明了主要信號分子（包括TRAF6、TAK1、IRE1、PERK和MyD88）在調節骨骼肌質量和癌症惡病質中的作用。他的研究計劃廣泛使用裸鼠、基因敲除和轉基因小鼠模型。庫馬博士已發表超過120篇同行評審的論文，指導了60多名學生、博士後和年輕教職員，並定期為70多本期刊和主要資助機構（包括NIH）進行審稿。

高塔姆·塞提博士是新加坡國立大學（National Uni. of Singapore）楊盧林醫學院藥理學系的副教授。他的研究主要探討致癌物和炎症因子如何激活致癌轉錄因子，旨在利用多樣的模型系統識別癌症預防和治療的新型抑制劑。他的工作已在高影響力的同行評審期刊上發表超過500篇科學論文。此外，塞提博士作為多本國際知名期刊的編輯委員會成員和臨時審稿人，為藥理學和癌症研究的進展做出了貢獻。他在全球享有很高的聲譽，持續被認為是世界上被引用最多的科學家之一，並於2020年和2021年被評選為Clarivate的高被引研究者（Highly Cited Researchers(TM)）。此外，他在2020-2025年期間被列入斯坦福大學的全球前2%科學家名單，專注於腫瘤學和致癌學。